The Daily Scan

May 16, 2018

Last Updated: 9:00 AM EST

Litigation

  • The Department of Justice announced yesterday that on April 13, 2018, the United States intervened in five lawsuits accusing Insys Therapeutics Inc., of violating the False Claims Act in connection with the marketing of Subsys, an opioid painkiller manufactured and sold by Insys. The U.S. alleges that Insys, headquartered in Arizona, paid kickbacks to induce physicians and nurse practitioners to prescribe Subsys for their patients. (Justice.gov)

 

  • Yesterday a California judge overturned the state’s physician-assisted suicide statute, ruling that lawmakers did not have the authority to pass it during a special session convened to take up healthcare legislation. California Attorney General Xavier Becerra said in a statement that his office “strongly disagreed” with the judge’s finding and would seek an expedited appeal. (Reuters.com)

 

  • Yesterday Tennessee Attorney General Herbert Slatery and Florida’s Pam Bondi accused executives of Purdue and other opioid makers and distributors of fueling a public-health crisis by falsely claiming that the synthetic pain medicine wasn’t addictive. They joined more than 20 other states that have sued companies including Purdue, Johnson & Johnson and McKesson Corp. over the products. (Fortune.com)

Legislation & Regulation

 

  • As a component of the new American Patients First initiative, the Centers for Medicare and Medicaid released a redesigned version of the Drug Pricing Dashboards yesterday in an effort to increase transparency. The dashboards are interactive online tools that allow users to understand trends in drug pricing. (CMS.gov)

 

  • The U.S. Government Accountability Office (GAO) released a new report on Monday on "Fees and Challenges Associated with Patients' Access." The report found that some patients incurred fees they believed to be excessive to access their records; for example, patients with chronic conditions can have lengthy records, and copying costs can be significant. Also, some patients are unaware that they can challenge providers who deny them access. (GAO.gov)

Private Sector

  • Swiss pharmaceutical giant Novartis announced earlier this morning that Group General Counsel and Member of the Executive Commitee Felix Ehrat has decided tor retire from the company in the context of discussions surrounding Novartis' former agreement with Essential Consultants, owned by Michael Cohen. Mr. Ehrat said: "Although the contract was legally in order, it was an error. As a co-signatory with our former CEO, I take personal responsibility to bring the public debate on this matter to an end." (Novartis.com)

 

 

 

Please reload

Our Recent Posts

The Weekly Scan

April 26, 2019

The Weekly Scan

April 12, 2019

The Weekly Scan

April 5, 2019

1/1
Please reload

Tags

Please reload

 

©2018 by FHAS Inc.

1 PPG Place, 31st Floor,

Pittsburgh, PA 15222